By asianet
Who are the heroes that have inspired the careers of Nobel Prize winners? What difficulties have they encountered and how did they overcome them? Each and every one of us can now delve into the careers and personal lives of some of the biggest names in the world of science thanks to “Dialogs Beyond Borders,” … Continued
By asianet
– The challenge unites people in celebration of World Oral Health Day 2022, taking place on 20 March, by asking people to share fun photos and videos demonstrating how they look after their oral health for their happiness and well-being, and inspire others to do the same In celebration of World Oral Health Day 2022, … Continued
By asianet
–Members will play a vital role in evaluating potential investments into clinical-stage companies developing urgently needed antibiotics The AMR Action Fund, the world’s largest public-private partnership investing in the development of new antibiotics, today named nine appointees to its independent Scientific Advisory Board (SAB). Logo – https://mma.prnewswire.com/media/1736281/AMR_Action_Fund_Logo.jpg The SAB will help evaluate the scientific merit, … Continued
By asianet
CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and associated Packaging services, announced today the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in Portugal. Logo … Continued
By asianet
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar(R) (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate cancer. (Trelstar(R), a synthetic analogue of GnRH (Gonadotropin Releasing Hormone) developed by Debiopharm, will be marketed by Aspen … Continued
By asianet
CAS SciFinder Discovery Platform(TM) redefines its role in drug discovery with the inclusion of unique biosequence data collection and capabilities CAS, a division of the American Chemical Society specializing in scientific information solutions, announces the launch of a major expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over 2 … Continued
By asianet
*VivaZome Therapeutics wins top prize with its potential to provide off-the-shelf regenerative medicines. *Part of Cytiva’s BioChallenge global series, the inaugural challenge for the Australia and New Zealand region received 32 applications from various universities and companies. Cytiva, a global life sciences leader, announces the winner of its first BioChallenge for the Australia and New … Continued
By asianet
Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has authorized the company’s investigational new drug (IND) application of DB104 (liafensine) for treatment-resistant depression (TRD) to proceed, which enables Denovo to start a global Phase 2b clinical trial to assess the safety and … Continued
By asianet
— Till date more than 17300+ registrations have been received from nurses from 175 countries — The announcement comes as a response to increasing requests from nurses worldwide for more time to complete the documentation process, following the Covid-19 surge — Nurses from around the world can submit their nominations via www.asterguardians.com [http://www.asterguardians.com/] Launched on … Continued
By asianet
FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II [https://www.conceptmedical.com/press-release/transform-ii/] Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels) setting in motion a crucial trial in the Native Coronary Vessel Treatment domain. TRANSFORM II RCT, determined to explore and evaluate the treatment … Continued